# Ganglioglioma

> Página oficial: https://raras.org/doenca/ganglioglioma
> Fonte: Raras.org — Banco de Dados de Doenças Raras em Português (CC BY-NC-SA 4.0)
> Última atualização: 2026-05-07

## Identificadores

- **ORPHA**: 251949 — https://www.orpha.net/en/disease/detail/251949
- **CID-10**: D33.0

## Descrição clínica

A well differentiated, slow growing neuroepithelial neoplasm composed of neoplastic, mature ganglion cells and neoplastic glial cells. Some gangliogliomas show anaplastic features in their glial component and are considered to be WHO grade III. Rare cases of newly diagnosed gangliogliomas with grade IV (glioblastoma) changes in the glial component have also been reported. (Adapted from WHO)

## Epidemiologia e herança


## Ensaios clínicos ativos (6)

- **NCT04065776** [RECRUITING]: Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma — https://clinicaltrials.gov/study/NCT04065776
- **NCT06915649** [RECRUITING]: Exploration and Evaluation of Amygdalo-Hippocampectomy According to Prof. Coubes' Technique: An Anatomical, Clinical, and Educational Approach — https://clinicaltrials.gov/study/NCT06915649
- **NCT04648462** [RECRUITING]: Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology — https://clinicaltrials.gov/study/NCT04648462
- **NCT03919071** [ACTIVE_NOT_RECRUITING]: Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma — https://clinicaltrials.gov/study/NCT03919071
- **NCT03975829** [ACTIVE_NOT_RECRUITING]: Pediatric Long-Term Follow-up and Rollover Study — https://clinicaltrials.gov/study/NCT03975829
- **NCT03152318** [ACTIVE_NOT_RECRUITING]: A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 — https://clinicaltrials.gov/study/NCT03152318
- **NCT01288235** [COMPLETED]: Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation — https://clinicaltrials.gov/study/NCT01288235
- **NCT03434262** [COMPLETED]: SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors — https://clinicaltrials.gov/study/NCT03434262
- **NCT03900689** [COMPLETED]: Social Determinants of Health in Glioblastoma Population — https://clinicaltrials.gov/study/NCT03900689
- **NCT02684058** [COMPLETED]: Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors — https://clinicaltrials.gov/study/NCT02684058

## Importante

O Raras **não diagnostica e não prescreve**. Esta página é educativa e informativa.
Pacientes devem consultar profissionais de saúde qualificados para decisões clínicas.

---

**Citação sugerida**: Raras.org — Ganglioglioma. Disponível em: https://raras.org/doenca/ganglioglioma
**Formato HTML**: https://raras.org/doenca/ganglioglioma
**Formato RDF/Turtle**: https://raras.org/api/rdf?orpha=251949